On the other hand, pQTLs for CRP showed no association with CAD (Elliott et al, 2009); in this case, removing the effect of the genetic variants associated would result in a better scrutiny of CRP as a CAD biomarker. This evidence concerns the gene CRP and coronary artery disorder.